Gobiquity CEO Michael Brownell breaks down the mobile ophthalmology market from the viewpoint of a start-up that’s set to change how kids are diagnosed with amblyopia, the number one cause of vision loss in kids.
Michael Brownell joined Gobiquity as CEO in 2012, with prior experience in a variety of leadership roles in ophthalmology and other industries. Gobiquity closed Series A financing with Interwest in July 2013.
Michael was part of the initial management team at IntraLase, and at the time of acquisition by AMO he was VP of Product Development. While at AMO he had expanding responsibilities across multiple technology groups.